Alejandro Ruiz Health Industry Global Head at Multiplica
View from the Top
Alejandro Ruiz
Health Industry Global Head
Multiplica
Data analysis is and will remain a key part of business strategy in the health sector
Rafael Gual Cosío
Expert Contributor
Rafael Gual
Director General
CANIFARMA
https://mx.linkedin.com/in/rafael-gual-cos%C3%ADo-a316a538
https://twitter.com/canifarma?lang=es
http://www.canifarma.org.mx/
The foreseeable consequences could jeopardize the well-being of millions of patients and workers.
Sandra Sánchez
Expert Contributor
Sandra Sánchez-Oldenhage
Regional General Manager of the NoLA Region
Novartis Oncology
https://www.linkedin.com/in/sandrasanchezoldenhage/?originalSubdomain=mx
https://twitter.com/sandrasanchezyo?lang=es
https://www.novartis.com/our-company/novartis-oncology
Latin America faces a growing aging population and presence of chronic degenerative diseases. Thus, becoming a trusted partner is essential.
Sandra Sánchez
Expert Contributor
Sandra Sánchez
Regional General Manager of the NoLA Region
Novartis Oncology
https://www.linkedin.com/in/sandrasanchezoldenhage/
https://twitter.com/sandrasanchezyo?lang=es
https://www.novartis.com.mx/nuestro-trabajo/areas-terapeuticas/oncologia
Medicines account for a stable share of healthcare spending and we should not lose sight that they help patients avoid expensive hospital services.
antibiotic resistance
News Article
The prohibition of antibiotic purchases without a prescription was the first step Mexico took in order to improve AMR regulation
The development of a vaccine against COVID-19
News Article
The development of a vaccine against COVID-19 is showing significant advances. Could the whole world be able to access it?
COVID-19 MX
News Article
70 vaccines are on the trial, says WHO, while Big Pharma companies rush to find a quicker cure for the current growing numbers suffering from COVID-19
R&D
News Article
Pfizer, Novartis and Roche are among the list of pharmaceuticals actively searching for a possible treatment to end the COVID-19 pandemic
Karel Fucikovsky
View from the Top
Karel Fucikovsky
Director General
Pierre Fabre Médicament
Pierre Fabre is the third-largest French pharmaceutical laboratory.
Subscribe to BIG PHARMA